The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
Open accessAbstract
Purpose: Most patients with hepatocellular carcinoma (HCC) have associated chronic liver disease, the severity of which is currently assessed by the Child-Pugh (C-P) grade. In this international collaboration, we identify objective measures of liver function/dysfunction that independently influence survival in patients with HCC and then combine these into a model that could be compared with the conventional C-P grade. Patients and Methods: We developed a simple model to assess liver function, based on 1,313 patients with HCC of all stages from Japan, that involved only serum bilirubin and albumin levels. We then tested the model using similar cohorts from other geographical regions (n = 5,097) and other clinical situations (patients undergoing resection [n = 525] or sorafenib treatment for advanced HCC [n = 1,132]). The specificity of the model for liver (dys)function was tested in patients with chronic liver disease but without HCC (n = 501). Results: The model, the Albumin-Bilirubin (ALBI) grade, performed at least as well as the C-P grade in all geographic regions. The majority of patients with HCC had C-P grade A disease at presentation, and within this C-P grade, ALBI revealed two classes with clearly different prognoses. Its utility in patients with chronic liver disease alone supported the contention that the ALBI grade was indeed an index of liver (dys)function. Conclusion: The ALBI grade offers a simple, evidence-based, objective, and discriminatory method of assessing liver function in HCC that has been extensively tested in an international setting. This new model eliminates the need for subjective variables such as ascites and encephalopathy, a requirement in the conventional C-P grade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“Liver function is currently graded according to the ChildPugh (C-P) system, which was originally developed to assess prognosis in patients with cirrhosis and portal hypertension undergoing surgery for variceal bleeding.(3,4) The C-P grade (which is based on a score derived from five parameters including conventional l…”
MethodA New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Dichotomizing continuous predictors in multiple regression: a bad idea
Royston, P., Altman, D. G., & Sauerbrei, W. (2006) · Statistics in Medicine · doi:10.1002/sim.2331 · Cited by 2,312
(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Surgery and portal hypertension.
Child, C. G., & Turcotte, J. (1964) · PubMed · Cited by 1,933
Cheng, A.-L., Kang, Y.-K., Lin, D.-Y., Park, J.-W., Kudo, M., Qin, S., Chung, H.-C., Song, X., Xu, J., Poggi, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8372 · Cited by 777
Johnson, P. J., Qin, S., Park, J.-W., Poon, R. T. P., Raoul, J.-L., Philip, P. A., Hsu, C.-H., Hu, T.-H., Heo, J., Xu, J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4410 · Cited by 772
Self-citationAssessment of the prognosis of cirrhosis: Child–Pugh versus MELD
Durand, F., & Valla, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.015 · Cited by 656
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603
Comparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D
Newson, R. B. (2010) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1001000303 · Cited by 424
Assessment of Prognosis of Cirrhosis
Durand, F., & Valla, D. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040325 · Cited by 410
Hepatocellular carcinoma: A worldwide problem and the major risk factors
Simonetti, R. G., Camm�, C., Fiorello, F., Politi, F., D'Amico, G., & Pagliaro, L. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297149 · Cited by 387
Botta, F., Giannini, E., Romagnoli, P., Fasoli, A., Malfatti, F., Chiarbonello, B., Testa, E., Risso, D., Colla, G., & Testa, R. (2003) · Gut · doi:10.1136/gut.52.1.134 · Cited by 358
Fattovich, G. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05474-6 · Cited by 333
Confidence Intervals for Rank Statistics: Somers’ D and Extensions
Newson, R. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600302 · Cited by 269
Cirrhosis and the aetiology of hepatocellular carcinoma
Johnson, P. J., & Williams, R. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80021-1 · Cited by 174
Self-citationStaging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers
Toyoda, H., Kumada, T., Osaki, Y., Oka, H., Urano, F., Kudo, M., & Matsunaga, T. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.021 · Cited by 132
Self-citationShetty, K., Rybicki, L. A., & Carey, W. D. (1997) · Hepatology · doi:10.1002/hep.510250501 · Cited by 129
Chan, S. L., Mo, F. K. F., Johnson, P. J., Liem, G. S., Chan, T. C., Poon, M. C., Ma, B. B. Y., Leung, T. W. T., Lai, P. B. S., Chan, A. T. �., et al. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06329.x · Cited by 92
Self-citationBiomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
Fox, R., Berhane, S., Teng, M. J., Cox, T. F., Tada, T., Toyoda, H., Kumada, T., Kagebayashi, C., Satomura, S., & Johnson, P. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.130 · Cited by 65
Self-citationToyoda, H., Kumada, T., Kiriyama, S., Sone, Y., Tanikawa, M., Hisanaga, Y., Yamaguchi, A., Isogai, M., Kaneoka, Y., & Washizu, J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.007 · Cited by 63
Self-citationTreatment of continuous data as categoric variables in
DELPRIORE, G., Zandieh, P., & LEE, M. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00504-2 · Cited by 39
van Dam, G. M., Gips, C., Reisman, Y., Maas, K. W., Purmer, I. M., Huizenga, J. R., & Verbaan, B. W. (1999) · PubMed · Cited by 13
Taktak, A. F. G., Eleuteri, A., Lake, S. P., & Fisher, A. C. (2008) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2008.04.005 · Cited by 12
Johnson, P., Berhane, S., Satomura, S., Tada, T., Kumada, T., Teng, M. J., Skowrońska, A., Cox, T. F., Palmer, D. H., Yeo, W., et al. (2014) · Journal of Hepatology · doi:10.1016/s0168-8278(14)60112-4 · Cited by 9
Self-citation
Research works printed but not linked: 7
- 10.1111/j.1572-0241.2002.07057.x · doi:10.1111/j.1572-0241.2002.07057.x · Paper page
- Child CG, 1964, Major Probl Clin Surg, 1, 1
- Johnson PJ, Presented at International Liver Congress London, European Association for the Study of the Liver
- Liver Cancer Study Group of Japan, 2003, The General Rules for the Clinical and Pathological Study of Primary Liver Cancer (English ed)
- Taktak A, 2007, Comput Intell Med
- 10.18773/austprescr.2001.009 · doi:10.18773/austprescr.2001.009
- Miksad RA, 2014, J Clin Oncol, 32
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Self-citation
Metadata
- Authors
- Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., Yeo, W., Mo, F., Lai, P., Iñarrairaegui, M., Chan, S. L., Sangro, B., Miksad, R., Tada, T., Kumada, T., & Toyoda, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-02-20
- Volume
- 33
- Issue
- 6
- Pages
- 550-558
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2119190881
- Cited by
- 2,783
- References
- 29
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.